NMPA Approval

Recombinant Human Basic Fibroblast Growth Factor for External Use

Approval Number

国药准字S20258001

Company北京双鹭药业股份有限公司

Registration Date

January 24, 2025

Previous Approval Numbers

国药准字S20020023

Drug Information

Generic Name

外用重组人碱性成纤维细胞生长因子

Trade Name

扶济复

Dosage Form

冻干制剂

Strength

70000IU/瓶

Drug Type

生物制品

Registration Date

January 24, 2025

Company Information

Applicant Company

Company Name北京双鹭药业股份有限公司

Company Address

北京市海淀区阜石路69号碧桐园1号楼4层

Manufacturing Company

Company Name北京双鹭药业股份有限公司

Company Address

北京市石景山区八大处高科技园区中园路 9 号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.